Abstract: 23
Pathway and cell-type signatures are patterns present in transcriptome data that are 24 associated with biological processes or phenotypic consequences. These signatures result from 25 specific cell-type and pathway expression, but can require large transcriptomic compendia to 26 detect. Machine learning techniques can be powerful tools in a practitioner's toolkit for 27 signature discovery through their ability to provide accurate and interpretable results. In the 28 following review, we discuss various machine learning applications to extract pathway and cell-29 type signatures from transcriptomic compendia. We focus on the biological motivations and 30 interpretation for both supervised and unsupervised learning approaches in this setting. We 31 consider recent advances, including deep learning, and their applications to expanding bulk and 32 single cell RNA data. As data and compute resources increase, opportunities for machine 33 learning to aid in revealing biological signatures will continue to grow. 34 35 perturbations are captured in the transcriptome (3). In the following review, we consider the 48 systems biology perspective that transcriptome measurements provide (Figure 1) . 49 A significant challenge to transcriptome analyses is making sense of the high 50 dimensional data. After data processing, there are many mechanisms by which hypotheses can 51 be tested and generated (4). One strategy uses machine learning, which is capable of rapidly 52 deriving insight and providing accurate results. Machine learning is a branch of computer 53 science used to derive solutions based on high dimensional input data and a target goal. By 54 optimizing the target goal, or objective function, the computer automatically learns a specific, 55 and potentially insightful, solution. There are many different machine learning algorithms, each 56 with different costs and benefits, including logistic regression, support vector machines (SVM), 57 mitigate this process, termed overfitting, a portion of the data is held out from training and 73 evaluated later . 74 In general, there are two basic flavors of machine learning: Supervised and unsupervised 75 learning. Each class can be used with varying goals, but the fundamental purpose of each is the 76 same: Testing how well the model captures the underlying target biology and determining if the 77 biology is consistent when the model is applied to new data. While there are certainly other 78 classes of machine learning -such as semi-supervised learning, reinforcement learning, 79 distantly and weakly supervised learning, and others (5), we focus here on supervised and 80 unsupervised learning, as they cover the most common applications in transcriptome research. 81
Early efforts applying supervised machine learning to transcriptome data were largely 82 successful. However, the approaches involved relatively simple supervised classification tasks 83 such as cancer vs. normal detection (6, 7), outcome prediction (8), or gene module detection (9, 84 10). Additionally, early unsupervised tasks like cancer subtype discovery (11) and gene pattern 85 identification (12) were also applied. These pioneering studies included relatively few samples, 86 and the target biology resulted in large sources of variation. Larger datasets allow investigators 87 to test more specific hypotheses and extract more subtle expression patterns. Many current 88 machine learning algorithms applied to transcriptome data involve more subtle tasks, including 89 the detection and characterization of cell-type and pathway-based signatures that exist in an 90 underlying subspace of the observable data. 91
The extraction of cell-type and pathway specific gene expression signatures can reveal 92 the function and heterogeneity of transcriptome data and are often the result of molecular 93 perturbations that may be important to a disease or phenotype of interest (13-16). Machine 94 learning methods can extract biological signals (17). In the following review, we highlight 95 specific machine learning techniques applied to transcriptomic compendia to reveal underlying 96 patterns representing cell-type and pathway signatures. We discuss supervised and 97 unsupervised machine learning for tasks including cell-type deconvolution, expression signature 98 discovery for the prediction of pathway activity, and the use of dimensionality reduction, or 99 compression, to uncover and explain hidden cellular states. We also discuss recent machine 100 learning approaches to extract pathway activity in single cell data and recent deep learning 101 algorithm advancements. Lastly, we focus on specific challenges associated with interpreting 102 machine learning models. 103 104
Supervised learning to isolate expression signatures 105
Supervised machine learning applied to transcriptome data is a powerful approach to 106 test hypotheses about a given model system and to make predictions based on target biology. 107
Leveraging the ability of the transcriptome to capture the differential mechanisms underlying 108 biological states (see Figure 1 ), supervised machine learning can stratify samples and states that 109 are based on specific cell-type or pathway signatures. In the following subsection, we 1) broadly 110 introduce supervised learning methodology, 2) briefly discuss initial landmark studies applying 111 supervised machine learning to transcriptome data, and 3) conclude with a review of current 112 studies that train supervised models on large transcriptomic compendia to derive pathway and 113 cell-type signatures. 114 115
A brief overview of supervised machine learning methodology 116
The goal of supervised machine learning is to train a computer to determine the status 117 of a known sample and to make accurate predictions on a new sample (18). Generally, the 118 models receive as input an data matrix and a length n vector y. Here, n refers to the 119 number of samples, p is the number of features, and y represents the predefined status, or 120 target classes. In many supervised learning algorithms, and often through an iterative learning 121 process, such as stochastic gradient descent, the models reach a solution of weights w that are 122 optimized against the classification or regression task. Additionally, various algorithms place 123 different emphasis on the training process and restricting, or regularizing, the solution of 124 weights. For example, one common algorithm is logistic regression, which can add penalty 125 terms like Lasso or elastic net into the objective function, which will enforce sparse solutions 126 (19, 20) . SVMs maximize the distance between class labels in feature space and RFs will 127 determine, over many iterations, features to split samples on based on information content 128 (21, 22). There have been many applications of supervised machine learning across a variety of 129 domains. Here, we focus on supervised learning applied to deriving cell-type and pathway 130 signatures. 131 132
Initial successes of supervised machine learning applied to transcriptome data 133
Various supervised learning algorithms have been applied to transcriptome data for 134 nearly two decades (23). In this setting, the input X matrix is typically n samples by p gene 135 expression features, and the y vector is defined based on a target hypothesis or measured 136 value. When it is important that only a few genes explain the target hypothesis, a practitioner 137 may prefer models that are constrained to provide sparse solutions, whereby only a small 138 percentage of measurable genes contribute to performance. Sparsity may be helpful to define 139 biomarker panels for downstream analyses. For example, a sparse classifier predicted 140 metastases in breast cancer (24). This discovery led to the 70-gene Mammaprint panel, 141 demonstrating that only 70 genes need to be measured to predict breast cancer severity. 142
However, careful validation of prognostic signatures must be performed, as over 90% of gene 143 signatures with 100 random genes were associated with breast cancer outcomes (25). 144
Additional pioneering applications of supervised learning to gene expression data included 145 identifying top genes that differentiated acute lymphoblastic leukemia (ALL) from acute 146 myeloid leukemia (AML) (7), distinguishing tumor from normal biopsies (6), predicting 147 treatment response in lymphoma (8), and predicting the function of novel yeast open reading 148 frames (9). These studies were performed on microarray data and were limited to small sample 149 sizes. Therefore, the target goals of the approaches required the two classes to contain large 150 differences in signal. While these studies did not directly interrogate hypotheses relating to cell-151 type and pathway activity, the signals identified may have represented differential cell-type or 152 pathway expression. Current applications train machine learning models on datasets that are 153 orders of magnitude larger, and can thus detect more subtle signatures hidden in the data. cell-type deconvolution methods require some signature matrix as input that has predefined 163 marker genes or proportion estimates of cell-types. Some form of linear regression will incorporate 164 this information to generate estimates of cell-type proportion. (Bottom) Supervised learning 165 applied to large transcriptomic compendia with a targeted hypothesis can stratify samples based on 166 pathway activity. The models can be used in classification or regression to provide binary labels or 167 continuous activation estimates, respectively. 168 169 regression and borrows information from sets of predefined marker genes or proportion 170 estimates associated with specific cell-types. One method, CIBERSORT, requires an input 171 signature matrix of immune cell marker genes which, through support vector regression (SVR), 172 deconvolves an input gene expression matrix from bulk tissue (26). Similar approaches use 173 linear regression based on other predefined cell-type signature matrices to deconvolve immune 174 cell-types. This approach has been applied to bulk cancer and systemic lupus erythematosus 175 (SLE) gene expression data (27, 28). Other deconvolution algorithms implement least squares 176 regression with input proportion matrices predefined in various ways. For example, the 177 matrices can be defined by cell-type specific probes (29), by using purified reference samples 178 (30), or from a pathologist's estimation (31). In a related study with different goals, an in-silico 179 dissection approach trained an SVM on bona-fide cell-type specific genes to identify other 180 genes in a guilt-by-association analysis (32). Other cell-type deconvolution methods exist 181 (reviewed in 33), and many are based on unsupervised learning to reveal underlying patterns 182 present (discussed in section 3.3). 183
Another use case for supervised learning is to stratify samples based on pathway activity 184 ( Figure 2 ). A key step in this process is to assign accurate labels to samples that exhibit pathway 185 misregulation. Assigning the correct status to a sample is costly, difficult, and often inaccurate. Other supervised learning algorithms and custom modifications have been applied to 206 detecting pathway activity in transcriptomes. For example, custom SVM variants and boosting 207 methods have been applied to identify mechanisms that increase malignancy in tumors (40). 208
Including biological knowledge a priori in the classification task during training can also aid in 209 feature selection and pathway activity stratification (41). Furthermore, one class learning 210 regression (OCLR) algorithms train models on gold standard gene expression of specific tissues 211 or pathways, and can generalize to other datasets without knowledge of negative labels (42). 212
This approach was recently applied to predicting oncogenic potential, or stemness, in TCGA 213
PanCanAtlas tumors (43). A similar approach, positive unlabeled learning (PU), uses gold 214 standard positively labeled genes alone to implicate other disease associated genes (44). 215 Supervised learning has also been applied to single cell transcriptome data. For example, 216 supervised learning has been applied to detect marker genes in neocortical cells (45). A neural 217 network based approach can also be used to predict cellular state and cell-type (46). Generative 218 adversarial networks, which train two competing neural networks (47), have been trained to 219 simulate single cell gene expression profiles, which can identify rare cell populations (48, 49). In 220 conclusion, supervised learning can determine specific cell-type and pathway activity and can 221 test hypotheses directly. However, sample labels are costly and often inaccurate. It is also 222 important to assess performance of these models in alternative datasets and to provide 223 orthogonal biological evidence when making conclusions. 224 225
Unsupervised machine learning to discover hidden expression states 226
Unsupervised machine learning identifies underlying structure in data without the need 227 for sample labels (50). The goals of unsupervised learning include clustering samples into 228 similar groups and identifying hidden, or latent, variables present in lower dimensional 229 subspaces. Applied to gene expression data, unsupervised learning has been used to identify 230 disease subtypes (11), deconvolve cell-types (33), and extract underlying gene expression 231 modules present in various percentages in lower dimensional data representations (51). In the 232 following subsection, we 1) broadly introduce unsupervised learning methodology, 2) discuss 233 the extraction of cell-types from expression data in an unsupervised manner, and 3) review a 234 series of recent publications that train dimensionality reduction, or compression, models on 235 large transcriptomic compendia to uncover hidden representations in data that reflect pathway 236 activity. 237 238 239 240
A brief overview of unsupervised machine learning algorithms 241
The input to unsupervised learning models is an n x p data matrix X where n represents 242 the number of samples, and p represents the number of features. In many unsupervised 243 algorithms, the models learn through minimizing reconstruction cost ( 
). The 244 algorithms reconstruct the input matrix after passing the data through one or more 
Unsupervised machine learning to uncover cell-types 282
Unsupervised learning can be used as a powerful approach to extract cell-type 283 signatures in transcriptomic compendia (Figure 3) . Several unsupervised algorithms have been 284 used for cell-type deconvolution including self-organizing maps (SOM), hierarchical clustering, 285 and matrix decomposition methods like NMF and singular value decomposition (SVD) (57, 52, 286 33). NMF is used to deconvolve gene expression data to identify differentially expressed genes 287 when no marker genes or reference data exists (58, 59). The NMF core algorithm can be guided 288 to identify cell-types by restricting the component matrix columns to sum to 1 (60). 289
Additionally, a Markov Chain Monte Carlo (MCMC) approach has been proposed to estimate 290 cell-type proportions in an unsupervised fashion (61). Nearest shrunken centroids, which 291 minimizes the number of genes required to describe subtypes (62), was also used to 292 deconvolve tumors into malignant, nonmalignant, and stroma components (63). It is also likely 293 that other compression algorithms, in addition to NMF, also capture cell-type associations in 294 their compressed latent spaces. However, proper interpretation of learned gene expression 295 components is required to determine if the observed signatures are representative of cell-type 296 expression. 297
One mechanism to obviate cell-type deconvolution is to directly measure single cell 298 expression profiles. There has been a recent explosion of unsupervised learning algorithms, 299 including NMF and autoencoders, applied to derive insight from single cell transcriptome data 300 (64-73). The application goals are usually batch correction, imputation, visualization, cell state 301 identification, or identifying pathway activity underlying homogenous cell-type populations. 302
These differential patterns of pathway activity can aid in cell state identification. For example, 303 differential pathway activity in a homogenous population of B cells in lupus patients was 304 predictive of patient outcome (74) . Additionally, by applying methods to increase the distance 305 between points in a homogenous cell-type population of Schistosoma parasites, Tarashansky et 306 al. 2018, identify subsets of cells which do not express specific marker genes previously thought 307 to be omnipresent (70) . Therefore, unsupervised models can keep pace with expanding data 308 and extract patterns at increasing resolution. algorithms applied to a high dimensional input matrix will automatically aggregate gene features 317 into a lower dimensional latent space. These latent spaces may represent pathway activities and 318 other biological processes. 319 320 321 hidden in latent spaces that represent a lower dimensional data manifold (Figure 3) . For 324 example, PCA applied to a large compendium of nearly 80,000 transcriptomes showed a strong 325 contribution of copy number alterations to disruptive gene signatures in cancer (75). ICA has 326 also been applied to transcriptome data to assign genes to gene modules and to identify 327 pathway signatures and other hidden transcriptional programs (76, 77, 51 reviewed in 78). In a 328 direct comparison, ICA outperformed PCA in identifying gene modules significantly related to 329 pathway activity in breast cancer samples (77). NMF is increasingly becoming the method of 330 choice to derive cell-type and pathway specific signatures from transcriptomic compendia (79-331 81). NMF does not constrain solutions to be orthogonal, and can therefore identify biological 332 processes that are known to be interconnected. A similar constrained latent variable approach 333 provides interpretable pathway signatures and can identify pathway specific activities while 334 isolating technical artifacts (82). This method, called PLIER, has been applied to large 335 compendia to train a model that can provide insight into rare diseases through transfer learning 336 (83). Other similar methods use Bayesian optimizations of matrix factorization to uncover 337 patterns of biological processes hidden in transcriptome data (81, 84) . 338 NMF identifies non-orthogonal linear patterns in data, which can be helpful in many 339 tasks. Different techniques can use non-linear activation functions to identify pathway activity 340 from transcriptomic compendia. For example, denoising autoencoders (DA) trained on a large 341 compendia of publicly available Pseudomonas transcriptomes were able to uncover biological 342 pathways associated with the pathogen's response to media and oxygen exposure (85, 86) Supervised learning models assign weights, or importance scores, to each gene 369 expression feature given a classification or regression task. For example, an RF model will 370 determine important gene expression features to split classes. Many methods have been 371 developed to rank RF feature importance, including an integration of Gene Ontology (GO) terms 372 to predict gene expression changes. This technique has been applied to determining important 373 genes in the aging process and response to chemical compounds in C. elegans (94, 95) . 374
Likewise, regression models and SVMs identify a subspace that represents specific activation 375 patterns in the input feature space. The magnitude of these features can be interpreted as the 376 most important genes for the classification task. Several methods penalize these scores using 377 recursive feature elimination and hinge loss penalties to reduce the number of explanatory 378 genes (96-98). A logistic regression model predicting Ras pathway activation identified similar 379 genes as a differential expression analysis (37). In general, however, caution must be exercised 380 when interpreting gene importance scores, since the algorithms can rely heavily on 381 initializations and different solutions are likely to implicate different genes (99). Models may 382 actually select correlated genes and ignore causal genes, which will be detrimental to 383 downstream interpretation. Neural network models are also particularly difficult to interpret. 384
The often "black-box" models learn many layers of features with increasing complexity, and it is 385 Lastly, the stability of unsupervised learning solutions is of utmost importance. Because 436 many are trained through an iterative process, the solutions identified will be different 437 depending on internal conditions. Therefore, it is important to recognize stable patterns 438 identified across various initializations. To this end, a method called stability NMF evaluates 439 solutions from multiple starting points and determines stable basis vectors, or principle 440 patterns, if they are consistently identified and correlated (108) . Ensemble models have been 441 used to aggregate solutions into a single model (86). Other methods have also been proposed 442 to assess stability of solutions including adding dropout to neural network models at test time 443 (109). Nevertheless, interpretation of machine learning models, model stability, and associating 444 compressed features with real biology is of paramount importance. 445
Conclusions 446
Machine learning applied to transcriptomic compendia reveals interesting substructure 447 in high dimensional data that often represent cell-type and pathway signatures. Both 448 supervised and unsupervised models have been successfully applied to derive expression 449 signatures with a variety of goals. As transcriptomic compendia continue to grow in size and 450 resolution, the need for rapid insight generation and decision-making abilities will also scale. In 451 many models, there are no restrictions on which signals the machine learning models learn, so 452 they can include artifacts and batch effects. Therefore, models must be applied to independent 453 datasets to confirm the learning of target biology. In addition to testing alternative data, 
